ArticleDrug safety2019

Evaluation of the Reported Rates of Severe Hypersensitivity Reactions Associated with Ferric Carboxymaltose and Iron (III) Isomaltoside 1000 in Europe Based on Data from EudraVigilance and VigiBase™ between 2014 and 2017.

Birgit Ehlken et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.